The hemoregulatory peptide N-acetyl-ser-asp-lys-pro impairs angiotensin I-induced contractions in rat aorta

被引:5
作者
Boulanger, CM
Ezan, E
Massé, F
Mathieu, E
Lévy, BI
Azizi, M
机构
[1] Hop Lariboisiere, INSERM, U141, F-75475 Paris 10, France
[2] CEA, Serv Pharmacol & Immunol, F-91191 Gif Sur Yvette, France
[3] Hop Broussais, INSERM, Ctr Invest Clin 9201, F-75674 Paris, France
[4] Hop Paris, F-75674 Paris, France
关键词
angiotensin II; angiotensin I; angiotensin converting enzyme; vascular tone; aorta; (rat); Ac-SDKP (N-acetyl-seryl-aspartyl-lysyl-proline);
D O I
10.1016/S0014-2999(98)00820-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The hemoregulatory peptide N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) is degraded by ACE. This study was designed to examine the effect of Ac-SDKP on the contractions to angiotensin I. Experiments were performed on rat aortic rings with endothelium exposed to nitro-L-arginine. Ac-SDKP (10 and 100 mu M) significantly augmented angiotensin I ED20 (from 2.0 +/- 0.4 to 4.2 +/- 1.0 and 5.0 +/- 0.9 nM) and ED50 (from 4.3 +/- 0.7 to 8.6 +/- 1.0 and 10.7 +/- 1.3 nM, respectively), but did not alter its maximal response. The contractions to angiotensin II were not affected by Ac-SDKP. No degradation of exogenous Ac-SDKP nor detectable release of endogenous Ac-SDKP were observed in the incubation medium. These results suggest that Ac-SDKP impairs angiotensin I response by inhibiting ACE and subsequent angiotensin II formation. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:153 / 156
页数:4
相关论文
共 19 条
[1]   High plasma level of N-acetyl-seryl-aspartyl-lysyl-proline - A new marker of chronic angiotensin-converting enzyme inhibition [J].
Azizi, M ;
Ezan, E ;
Nicolet, L ;
Grognet, JM ;
Menard, J .
HYPERTENSION, 1997, 30 (05) :1015-1019
[2]   Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline [J].
Azizi, M ;
Rousseau, A ;
Ezan, E ;
Guyene, TT ;
Michelet, S ;
Grognet, JM ;
Lenfant, M ;
Corvol, P ;
Menard, J .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (03) :839-844
[3]   ENDOTHELIAL AT(1)-MEDIATED RELEASE OF NITRIC-OXIDE DECREASES ANGIOTENSIN-II CONTRACTIONS IN RAT CAROTID-ARTERY [J].
BOULANGER, CM ;
CAPUTO, L ;
LEVY, BI .
HYPERTENSION, 1995, 26 (05) :752-757
[4]   EFFECT OF A NEW ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK 421 AND ITS LYSINE ANALOG ON THE COMPONENTS OF THE RENIN SYSTEM IN HEALTHY-SUBJECTS [J].
BRUNNER, DB ;
DESPONDS, G ;
BIOLLAZ, J ;
KELLER, I ;
FERBER, F ;
GAVRAS, H ;
BRUNNER, HR ;
SCHELLING, JL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (05) :461-467
[5]   EFFECTS OF CONVERTING-ENZYME INHIBITORS ON ANGIOTENSIN AND BRADYKININ PEPTIDES [J].
CAMPBELL, DJ ;
KLADIS, A ;
DUNCAN, AM .
HYPERTENSION, 1994, 23 (04) :439-449
[6]   LOCALIZATION OF ANGIOTENSINOGEN MESSENGER-RNA IN RAT AORTA [J].
CASSIS, LA ;
LYNCH, KR ;
PEACH, MJ .
CIRCULATION RESEARCH, 1988, 62 (06) :1259-1262
[7]  
DZAU VJ, 1994, CARDIOVASCULAR PHARM, P237
[8]  
EZAN E, 1994, DRUG METAB DISPOS, V22, P843
[9]   In vitro modulation of a resistance artery diameter by the tissue renin-angiotensin system of a large donor artery [J].
Henrion, D ;
Benessiano, J ;
Levy, BI .
CIRCULATION RESEARCH, 1997, 80 (02) :189-195
[10]   MODULATION OF ANGIOTENSIN-II-INDUCED VASOCONSTRICTION BY ENDOTHELIUM-DERIVED RELAXING FACTOR IN THE ISOLATED MICROPERFUSED RABBIT AFFERENT ARTERIOLE [J].
ITO, S ;
JOHNSON, CS ;
CARRETERO, OA .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (05) :1656-1663